Chronic traumatic encephalopathy

From WikiMD's WELLNESSPEDIA

(Redirected from Dementia pugilistica)


Chronic traumatic encephalopathy
Chronic Traumatic Encephalopathy.png
A normal brain (left) and one with advanced CTE (right)
Synonyms Traumatic encephalopathy syndrome, dementia pugilistica, punch drunk syndrome


Specialty Neurology, psychiatry, sports medicine
Symptoms Behavioral problems, mood problems, problems with thinking
Complications Brain damage, dementia, depression,
Usual onset Years after initial injuries



Causes Repeated head injuries
Risk factors Contact sports, military, domestic abuse, repeated banging of the head
Diagnosis Autopsy
Differential diagnosis Alzheimer's disease, Parkinson's disease


Treatment Supportive care


Prognosis Worsens over time
Frequency Uncertain


Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that has been associated with repetitive head trauma, such as that experienced by athletes involved in contact sports and military veterans. CTE is characterized by the accumulation of an abnormal form of the tau protein in the brain, leading to a range of cognitive, behavioral, and emotional symptoms. The disease can only be definitively diagnosed through post-mortem examination of the brain.

Symptoms[edit]

  • Symptoms of chronic traumatic encephalopathy may vary among individuals but can include:
  • Memory loss
  • Confusion
  • Impaired judgment
  • Aggression
  • Depression
  • Anxiety
  • Impulse control problems
  • Suicidal behavior
  • The severity of symptoms and the rate of disease progression can differ significantly among affected individuals.

Causes and risk factors[edit]

  • CTE is believed to be caused by repetitive head trauma, which can result in the accumulation of an abnormal form of the tau protein in the brain. This accumulation is thought to disrupt normal brain function and contribute to the development of symptoms. Factors that may increase the risk of developing CTE include:
  • A history of head injuries, including concussions and sub-concussive impacts
  • Participation in contact sports, such as American football, boxing, rugby, and ice hockey
  • Military service, particularly if exposed to blast injuries or other forms of head trauma
  • Genetic predisposition

Diagnosis[edit]

  • Currently, the diagnosis of chronic traumatic encephalopathy can only be definitively made through a post-mortem neuropathological examination of the brain. Researchers are working to develop diagnostic criteria and imaging techniques that may allow for the identification of CTE in living individuals.

Treatment[edit]

  • There is no cure for chronic traumatic encephalopathy, and treatment focuses on managing symptoms and providing supportive care. This may include:
  • Medications to manage symptoms, such as antidepressants, anti-anxiety medications, or medications to address cognitive dysfunction
  • Psychotherapy to address emotional and behavioral symptoms
  • Occupational therapy and cognitive rehabilitation to improve daily functioning
  • Supportive care for individuals and their families
  • Prevention of head injuries, particularly in contact sports and military service, is critical for reducing the risk of CTE.

Prevalence[edit]

  • The prevalence of chronic traumatic encephalopathy is unknown, as the disease can only be diagnosed post-mortem. However, research has primarily reported cases of CTE in athletes involved in contact sports and military veterans.

See also[edit]

References[edit]

External links[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.